Introduction to Gilotrif (Afatinib) 200mg
Gilotrif (Afatinib) 200mg is a prescription targeted therapy used in the treatment of certain types of lung cancer, particularly non-small cell lung cancer (NSCLC) with EGFR mutations. It belongs to a class of advanced anticancer drugs that specifically block cancer growth signals.
Fenitab® (Afatinib) 200mg is classified under Prescription Medicines, Oncology Medicines, Targeted Therapy, and Anticancer Drugs. It contains Afatinib, which works by inhibiting specific proteins responsible for tumor growth and progression.
In many markets, Gilotrif is available as the original brand containing the same active ingredient Afatinib, offering similar therapeutic benefits when prescribed by a qualified healthcare professional.
What Is Gilotrif (Afatinib) 200mg?
Afatinib is an oral targeted therapy medicine used to treat specific types of lung cancer by blocking abnormal cell signaling pathways.
Afatinib belongs to a class of medicines known as Tyrosine Kinase Inhibitors (TKIs). These drugs inhibit epidermal growth factor receptor (EGFR) pathways involved in cancer cell growth.
Generic brands such as Fenitab® 200mg contain the same active compound and may be used depending on physician recommendation and availability.
Drug Class and Mechanism of Action
How Afatinib Works
- Irreversibly blocks EGFR and related receptors
- Inhibits tumor cell signaling pathways
- Prevents cancer cell growth and spread
These mechanisms help slow or stop tumor progression.
How Gilotrif Works in the Body
Afatinib targets abnormal proteins that drive cancer cell growth in EGFR-mutated tumors.
Key Actions of Afatinib
- Blocks EGFR signaling pathways
- Stops cancer cell proliferation
- Promotes apoptosis (cell death)
Medical Uses of Gilotrif (Afatinib) 200mg
Afatinib for Non-Small Cell Lung Cancer (NSCLC)
Primarily used in patients with EGFR mutation-positive NSCLC.
Potential Benefits
- Targets specific cancer mutations
- Slows disease progression
- Improves survival outcomes
Who Can Take Fenitab® 200mg?
Eligibility Criteria
Patients may be prescribed this medicine if they:
- Have EGFR mutation-positive NSCLC
- Are suitable for targeted therapy
- Have adequate organ function
Who Should Avoid Gilotrif (Afatinib) 200mg
This medicine should NOT be used by:
- Pregnant or breastfeeding women
- Patients with severe liver or kidney issues (unless monitored)
- Individuals allergic to Afatinib
Gilotrif (Afatinib) 200mg Dosage and Administration
Standard Dosage Guidelines
- Typically taken once daily
- Taken on an empty stomach (at least 1 hour before or 2 hours after food)
- Swallowed whole with water
Dosage Adjustments
Doctors may adjust dosage based on:
- Side effects
- Patient tolerance
- Liver and kidney function
Side Effects of Gilotrif (Afatinib) 200mg
Common Side Effects
- Diarrhea
- Skin rash or acne
- Mouth sores
- Decreased appetite
Serious Side Effects
- Severe diarrhea leading to dehydration
- Lung inflammation (interstitial lung disease)
- Liver toxicity
- Severe skin reactions
Patients should contact their doctor if serious symptoms occur.
Storage
Store below 25°C in a cool, dry place. Protect from moisture and direct sunlight.
Frequently Asked Questions (FAQs)
1. What is Fenitab® 200mg used for?
It is used to treat EGFR mutation-positive non-small cell lung cancer.
2. Is Afatinib chemotherapy?
No, it is a targeted therapy, not traditional chemotherapy.
3. How should I take Fenitab® 200mg?
Take it on an empty stomach as directed by your doctor.
4. Can it be used long-term?
Yes, it may be used long-term under medical supervision.
5. Can pregnant women take Afatinib?
No, it may harm the unborn baby.
6. Is Fenitab® the same as Gilotrif?
Yes, both contain Afatinib and provide similar therapeutic effects.
7. Do I need a prescription?
Yes, it is a prescription-only medicine.
Medical Disclaimer
Disclaimer:
This content is for educational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional before using any medication.
